Janney Montgomery Scott LLC Ab Cellera Biologics Inc. Transaction History

Janney Montgomery Scott LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$4.6 - $7.95 $87,694 - $151,558	19,064 New	19,064 $88,000
Q1 2023 Apr 28, 2023	BUY	$7.31 - $11.18 $74,510 - $113,957	10,193 New	10,193 $77,000
Q2 2022 Aug 03, 2022	SELL	$5.72 - $10.65 $304,652 - $567,229	-53,261 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$7.46 - $14.14 $973,052 - $1.84 Million	-130,436 Reduced 71.01%	53,261 $519,000
Q4 2021 Jan 27, 2022	BUY	$12.99 - $17.73 $357,536 - $488,000	27,524 Added 17.62%	183,697 $2.63 Million
Q3 2021 Oct 29, 2021	BUY	$14.85 - $21.34 $1.37 Million - $1.97 Million	92,502 Added 145.28%	156,173 $3.13 Million
Q2 2021 Jul 26, 2021	BUY	$20.19 - $34.17 $1.01 Million - $1.71 Million	49,976 Added 364.92%	63,671 $1.4 Million
Q1 2021 Apr 27, 2021	BUY	$23.29 - $53.2 $318,956 - $728,574	13,695 New	13,695 $465,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.